Cargando…
The impact of pharmaceutical innovation on the burden of disease in Ireland, 2000–2015
BACKGROUND: We perform an econometric assessment of the impact that pharmaceutical innovation had on the burden of disease in Ireland. METHODS: We use a difference-in-differences (or two-way fixed effects) research design: we investigate whether diseases for which more new drugs were launched had la...
Autor principal: | Lichtenberg, Frank R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685853/ https://www.ncbi.nlm.nih.gov/pubmed/31927585 http://dx.doi.org/10.1093/pubmed/fdz183 |
Ejemplares similares
-
The impact of pharmaceutical innovation on the burden of disease in Canada, 2000–2016
por: Lichtenberg, Frank R.
Publicado: (2019) -
The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000–2011
por: Lichtenberg, Frank R.
Publicado: (2015) -
Opioid and analgesic utilization in Ireland in 2000 and 2015: A repeated cross‐sectional study
por: Moriarty, Frank, et al.
Publicado: (2021) -
Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000–2015
por: Loutet, Miranda G., et al.
Publicado: (2018) -
Trends and inequalities in the burden of mortality in Scotland 2000–2015
por: Mesalles-Naranjo, Oscar, et al.
Publicado: (2018)